Pfizer submitted application for emergency use of Covid vaccine
US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government... Read More
Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China
Posted on20 Nov 2020
Comments0
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Fresenius Kabi announced an agreement to develop, register and distribute Veltassa for the treatment... Read More
Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning
Posted on30 Oct 2020
Tagsgilead, Gilead Sciences, pharma strategic deal, Remdesivir, Strategic deal in pharma, strategic management in pharma, Veklury
Comments0
FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients 12 years of age... Read More
Sanofi and Merck to conduct phase 2 trial of THOR-707 in combo with Keytruda
Sanofi has entered into an agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the US and Canada)... Read More
Insight of BioInvent’s licensing deal of anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals
BioInvent licenses anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals for Greater China region. BioInvent have entered into an exclusive licensing agreement for the... Read More
Case Study: Rinvoq’s brand Dermatology market expansion strategy
Rinvoq is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Rinvoq is the brand of... Read More
Sobrera, Recipharm Collaborate to Advance Alcohol Use Disorder Treatment
Sobrera Pharma, and Recipharm have entered into an agreement for the formulation development and manufacturing of SO-001, a new oral treatment for... Read More
Centaur Pharma launches WOXheal to treat diabetic foot ulcers
Centaur Pharmaceuticals announced the launch of a new chemical entity (NCE) – WOXheal for the treatment of diabetic foot ulcers, and it... Read More
Insight on USFDA approval of pralsetinib to treat non-small lung cancer
Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S.... Read More
What is hybrid clinical trial?
Posted on15 Sep 2020
Comments0
AÂ hybrid trial is a type of clinical trial which includes both traditional and pragmatic clinical trial elements. Randomized controlled trials are generally... Read More